SEC Form 4 · accession 0001209191-17-033097
QUAKER CHEMICAL CORP · KWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph A Berquist
Officer — VP & Managing Director - NA
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000081362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2017 | M | 710 | $58.26 | A | 13,136 | D | |
| Common Stock | May 15, 2017 | F | 424 | $140.30 | D | 12,712 | D | |
| Common Stock | May 15, 2017 | M | 1,472 | $73.47 | A | 14,184 | D | |
| Common Stock | May 15, 2017 | F | 990 | $140.30 | D | 13,194 | D | |
| Common Stock | May 15, 2017 | M | 1,489 | $87.30 | A | 14,683 | D | |
| Common Stock | May 15, 2017 | F | 1,024 | $140.30 | D | 13,659 | D | |
| Common Stock | May 15, 2017 | M | 1,213 | $72.12 | A | 14,872 | D | |
| Common Stock | May 15, 2017 | F | 646 | $140.30 | D | 14,226 | D | |
| Common StockF1 | holding | — | — | — | 2,830 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $58.26 | May 15, 2017 | M | 710 | D | — | Mar 5, 2020 | Common Stock | 710 | 0 | D |
| Employee Stock Option (right to buy)F3 | $73.47 | May 15, 2017 | M | 1,472 | D | — | Feb 27, 2021 | Common Stock | 1,472 | 0 | D |
| Employee Stock Option (right to buy)F4 | $87.30 | May 15, 2017 | M | 1,489 | D | — | Feb 25, 2022 | Common Stock | 1,489 | 744 | D |
| Employee Stock Option (right to buy)F5 | $72.12 | May 15, 2017 | M | 1,213 | D | — | Feb 23, 2023 | Common Stock | 1,213 | 2,426 | D |
Explanation of responses
- F1Information based on reporting person's Plan Statement as of March 31, 2017.
- F2The options under this grant vested in three annual installments: 710 shares on March 5, 2014; 710 shares on March 5, 2015; and 710 shares on March 5, 2016.
- F3The options for this grant vested in three annual installments: 737 shares on February 27, 2015; 736 shares on February 27, 2016; and 736 shares on February 27, 2017.
- F4The options for this grant vest in three annual installments: 745 shares on February 25, 2016; 744 shares on February 25, 2017; and 744 shares on February 25, 2018.
- F5The options for this grant vest in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.